Potential methods to circumvent blocks in apoptosis in lymphomas

Research output: Contribution to journalArticle

Abstract

We review our current understanding of the molecular determinants and mechanisms of lymphocyte apoptosis and identify the key regulators of these death-signaling pathways. In addition, we describe the key molecular aberrations that underlie the resistance of lymphomas to conventional therapy, and highlight the enormous promise of potential therapeutic strategies that could circumvent or overcome these genetic impediments to apoptosis.

Original languageEnglish (US)
Pages (from-to)490-503
Number of pages14
JournalCurrent Opinion in Oncology
Volume14
Issue number5
DOIs
StatePublished - Sep 2002

Fingerprint

Lymphoma
Apoptosis
Lymphocytes
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

Potential methods to circumvent blocks in apoptosis in lymphomas. / Ravi, Rajani; Bedi, Atul.

In: Current Opinion in Oncology, Vol. 14, No. 5, 09.2002, p. 490-503.

Research output: Contribution to journalArticle

@article{388487910bdb4c40961132f1b8012538,
title = "Potential methods to circumvent blocks in apoptosis in lymphomas",
abstract = "We review our current understanding of the molecular determinants and mechanisms of lymphocyte apoptosis and identify the key regulators of these death-signaling pathways. In addition, we describe the key molecular aberrations that underlie the resistance of lymphomas to conventional therapy, and highlight the enormous promise of potential therapeutic strategies that could circumvent or overcome these genetic impediments to apoptosis.",
author = "Rajani Ravi and Atul Bedi",
year = "2002",
month = "9",
doi = "10.1097/00001622-200209000-00004",
language = "English (US)",
volume = "14",
pages = "490--503",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Potential methods to circumvent blocks in apoptosis in lymphomas

AU - Ravi, Rajani

AU - Bedi, Atul

PY - 2002/9

Y1 - 2002/9

N2 - We review our current understanding of the molecular determinants and mechanisms of lymphocyte apoptosis and identify the key regulators of these death-signaling pathways. In addition, we describe the key molecular aberrations that underlie the resistance of lymphomas to conventional therapy, and highlight the enormous promise of potential therapeutic strategies that could circumvent or overcome these genetic impediments to apoptosis.

AB - We review our current understanding of the molecular determinants and mechanisms of lymphocyte apoptosis and identify the key regulators of these death-signaling pathways. In addition, we describe the key molecular aberrations that underlie the resistance of lymphomas to conventional therapy, and highlight the enormous promise of potential therapeutic strategies that could circumvent or overcome these genetic impediments to apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=0036739765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036739765&partnerID=8YFLogxK

U2 - 10.1097/00001622-200209000-00004

DO - 10.1097/00001622-200209000-00004

M3 - Article

C2 - 12192267

AN - SCOPUS:0036739765

VL - 14

SP - 490

EP - 503

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 5

ER -